These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28401167)

  • 1. Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy.
    Zhu H; Liu M; Yu H; Liu X; Zhong Y; Shu J; Fu X; Cai G; Chen X; Geng W; Yang X; Wu M; Li Z; Zhang D
    J Diabetes Res; 2017; 2017():5728087. PubMed ID: 28401167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Value of
    Yang XL; Yu HJ; Zhu HY; Zheng Y; Han QX; Cai GY; Chen XM
    Chin Med J (Engl); 2018 Jan; 131(2):180-187. PubMed ID: 29336366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K; Imamura M; Yamaguchi S; Teshigawara S; Tone A; Uchida HA; Eguchi J; Nakatsuka A; Ogawa D; Yoshida M; Yamada M; Shikata K; Wada J
    Diabetes Care; 2018 Aug; 41(8):1765-1775. PubMed ID: 29930140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
    Inoue K; Wada J; Eguchi J; Nakatsuka A; Teshigawara S; Murakami K; Ogawa D; Terami T; Katayama A; Tone A; Iseda I; Hida K; Yamada M; Ogawa T; Makino H
    PLoS One; 2013; 8(10):e77118. PubMed ID: 24143207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary Glycopatterns as Potential Non-Invasive Biomarkers for Diagnosing and Reflecting Severity and Prognosis of Diabetic Nephropathy.
    Han Q; Wang X; Ding X; Hao J; Li Q; Wang J; Yu H; Tang Z; Yang F; Cai G; Zhang D; Zhu H
    Front Endocrinol (Lausanne); 2022; 13():790586. PubMed ID: 35432212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary proteomics in diabetes and CKD.
    Rossing K; Mischak H; Dakna M; Zürbig P; Novak J; Julian BA; Good DM; Coon JJ; Tarnow L; Rossing P;
    J Am Soc Nephrol; 2008 Jul; 19(7):1283-90. PubMed ID: 18448586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
    Chen CJ; Liao WL; Chang CT; Liao HY; Tsai FJ
    PLoS One; 2018; 13(7):e0200945. PubMed ID: 30024955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
    J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy.
    Shinada M; Akdeniz A; Panagiotopoulos S; Jerums G; Bach LA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1163-9. PubMed ID: 10720056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R; Torffvit O; Rippe B; Bakoush O
    Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy.
    Papale M; Di Paolo S; Magistroni R; Lamacchia O; Di Palma AM; De Mattia A; Rocchetti MT; Furci L; Pasquali S; De Cosmo S; Cignarelli M; Gesualdo L
    Diabetes Care; 2010 Nov; 33(11):2409-15. PubMed ID: 20671095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy.
    Suzuki K; Babazono T; Murata H; Iwamoto Y
    Diabetes Care; 2005 Aug; 28(8):2038-9. PubMed ID: 16043754
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay.
    Comper WD; Osicka TM; Clark M; MacIsaac RJ; Jerums G
    Kidney Int; 2004 May; 65(5):1850-5. PubMed ID: 15086926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients.
    Dihazi H; Müller GA; Lindner S; Meyer M; Asif AR; Oellerich M; Strutz F
    Clin Chem; 2007 Sep; 53(9):1636-45. PubMed ID: 17634209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.